13 May 2020
Posted in Pharma
Healthcare sector witnessed 4.4% growth in deal activity during week ended May 10
The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) grew by 4.4% during the week ended May 10, 2020 compared to the previous week, according to GlobalData’s deals database.
Aurojyoti Bose, Lead Analyst at GlobalData, comments: “The healthcare sector has been relatively resilient compared to other sectors and this is the fourth consecutive week of growth in deal activity amidst uncertainty and volatile market conditions due to the COVID-19 outbreak.”
Deal activity increased in key markets such as the UK, Canada, France and South Korea during the week ended May 10, 2020 compared to the previous week, while the US and China witnessed decline.
Mergers and acquisitions (M&A), equity offerings and licensing agreement deals volume increased by 29.4%, 42.9% and 38.5%, respectively, during the week ended May 10, 2020 compared to the previous week, while the number of partnership, private equity and venture financing deals declined by 6.8%, 69.2% and 46.7%.